These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2173691)

  • 41. Pathways for the response of the eye to injury.
    Jampol LM; Neufeld AH; Sears ML
    Invest Ophthalmol; 1975 Mar; 14(3):184-9. PubMed ID: 1116918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostanoid Receptor Antagonist Effects on Intraocular Pressure, Supported by Ocular Biodisposition Experiments.
    Woodward DF; Wenthur SL; Rudebush TL; Fan S; Toris CB
    J Ocul Pharmacol Ther; 2016 Nov; 32(9):606-622. PubMed ID: 27763812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The molecular biology and ocular distribution of prostanoid receptors.
    Woodward DF; Regan JW; Lake S; Ocklind A
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S15-21. PubMed ID: 9154272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostanoid stimulation of anion secretion in guinea-pig gastric and ileal mucosa is mediated by different receptors.
    Bunce KT; Spraggs CF
    Br J Pharmacol; 1990 Dec; 101(4):889-95. PubMed ID: 2085712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.
    Kirihara T; Taniguchi T; Yamamura K; Iwamura R; Yoneda K; Odani-Kawabata N; Shimazaki A; Matsugi T; Shams N; Zhang JZ
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):145-153. PubMed ID: 29332128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of topical betaxolol on the acute rise of aqueous flare induced by highly selective agonists for prostaglandin E2 receptor subtypes in pigmented rabbits.
    Yanagisawa S; Hayasaka S; Zhang XY; Hayasaka Y; Nagaki Y; Kitagawa K
    Ophthalmic Res; 2002; 34(1):48-50. PubMed ID: 11834885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorophotometric evaluation of experimental blood-aqueous barrier disruption in dogs.
    Ward DA; Ferguson DC; Kaswan RL; Green K; Bellhorn RW
    Am J Vet Res; 1991 Sep; 52(9):1433-7. PubMed ID: 1952328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The effect of prostaglandins on the blood-ocular barrier. I. Blood-aqueous barrier (author's transl)].
    Kohda N; Tsukahara S
    Nippon Ganka Gakkai Zasshi; 1976 Aug; 80(8):429-35. PubMed ID: 988715
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effects of prostaglandin on the blood-ocular barriers. I. Effects on the blood-aqueous barrier (author's transl)].
    Masunaga J
    Nippon Ganka Gakkai Zasshi; 1980; 84(5):427-37. PubMed ID: 7395677
    [No Abstract]   [Full Text] [Related]  

  • 50. Effects of intravenous calcitonin gene-related peptide (CGRP) and substance P on the blood-aqueous barrier in the rabbit.
    Andersson SE; Bill A
    Acta Physiol Scand; 1989 Mar; 135(3):349-57. PubMed ID: 2467520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels.
    Spada CS; Nieves AL; Woodward DF
    Exp Eye Res; 2002 Aug; 75(2):155-63. PubMed ID: 12137761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of platelets in blood-aqueous barrier breakdown induced by anterior chamber paracentesis in the rabbit.
    Latour E; Driot JY; Coquelet C; Bonne C
    Curr Eye Res; 1989 Nov; 8(11):1105-10. PubMed ID: 2515035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug prevention of blood-aqueous barrier disruption.
    van Haeringen NJ; Glasius E; Oosterhuis JA; van Delft JL
    Ophthalmic Res; 1983; 15(4):180-4. PubMed ID: 6634053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of topical iganidipine on experimental elevation of aqueous flare induced by prostaglandin E(2) and EP agonists in pigmented rabbits.
    Yanagisawa S; Hayasaka S; Zhang XY; Hayasaka Y; Nagaki Y
    Ophthalmic Res; 2002; 34(4):195-9. PubMed ID: 12297691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The affinity, intrinsic activity and selectivity of a structurally novel EP
    Coleman RA; Woodrooffe AJ; Clark KL; Toris CB; Fan S; Wang JW; Woodward DF
    Br J Pharmacol; 2019 Mar; 176(5):687-698. PubMed ID: 30341781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human EP2 prostanoid receptors exhibit more constraints to mutations than human DP prostanoid receptors.
    Tanimoto J; Fujino H; Takahashi H; Murayama T
    FEBS Lett; 2015 Mar; 589(6):766-72. PubMed ID: 25681680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of prostaglandin inhibitors on the laser-induced disruption of blood aqueous barrier in the rabbit.
    Schrems W; van Dorp HP; Mager S; Krieglstein GK
    Graefes Arch Clin Exp Ophthalmol; 1983; 221(2):61-4. PubMed ID: 6686176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel prostaglandin receptor modulators: a patent review (2002 - 2012) - part I: non-EP receptor modulators.
    Lamers C; Flesch D; Schubert-Zsilavecz M; Merk D
    Expert Opin Ther Pat; 2013 Jan; 23(1):47-77. PubMed ID: 23151189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostanoid-induced contraction of the rabbit isolated uterus is mediated by FP receptors.
    Chen J; Woodward DF; Yuan YD; Marshall K; Senior J
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):387-94. PubMed ID: 9653775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ocular responses and the release of prostaglandin-like substances by Shigella endotoxin.
    Bhattacherjee P
    J Physiol; 1975 Mar; 246(2):38P-39P. PubMed ID: 1142255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.